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Abstract
Susac syndrome, a rare but probably underdiagnosed combination of encephalopathy, hearing loss, and visual deficits due
to branch retinal artery occlusion of unknown aetiology has to be considered as differential diagnosis in various conditions.
Particularly, differentiation from multiple sclerosis is often challenging since both clinical presentation and diagnostic
findings may overlap. Optical coherence tomography is a powerful and easy to perform diagnostic tool to analyse the
morphological integrity of retinal structures and is increasingly established to depict characteristic patterns of retinal
pathology in multiple sclerosis. Against this background we hypothesised that differential patterns of retinal pathology
facilitate a reliable differentiation between Susac syndrome and multiple sclerosis. In this multicenter cross-sectional
observational study optical coherence tomography was performed in nine patients with a definite diagnosis of Susac
syndrome. Data were compared with age-, sex-, and disease duration-matched relapsing remitting multiple sclerosis
patients with and without a history of optic neuritis, and with healthy controls. Using generalised estimating equation
models, Susac patients showed a significant reduction in either or both retinal nerve fibre layer thickness and total macular
volume in comparison to both healthy controls and relapsing remitting multiple sclerosis patients. However, in contrast to
the multiple sclerosis patients this reduction was not distributed over the entire scanning area but showed a distinct
sectorial loss especially in the macular measurements. We therefore conclude that patients with Susac syndrome show
distinct abnormalities in optical coherence tomography in comparison to multiple sclerosis patients. These findings
recommend optical coherence tomography as a promising tool for differentiating Susac syndrome from MS.
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Introduction
Susac syndrome is a rare disease characterised by the clinical
triad of encephalopathy, vision disturbances, namely visual field
defects, and sensorineural hearing loss [1–3]. The exact prevalence
of Susac syndrome is unknown, and its pathogenesis is still unclear;
autoimmune processes that lead to an occlusion of small vessels in
the brain, retina and inner ear are believed to play an important
role [4,5]. The disease most often manifests in the third to fourth
decade [6]. The prognosis mainly depends on the severity, the
often self-limited and monophasic, sometimes fluctuating and
rarely relapsing clinical course [7], and the appropriate treatment
[8,9]. Retinal infarction presenting with scotoma is one of the
clinical hallmarks, although often not predominant. Patients can
present with episodic or permanent vision loss [6]. Fluorescein
angiography (FAG) and funduscopy show branch retinal artery
occlusions (BRAO), arterial wall hyperfluorescence and retinal
arterial wall plaques, termed Gass plaques [10]. Retinal involve-
ment can be missed in cases where patients do not complain about
visual disturbances due to neuropsychological impairment, or
when physicians are not familiar with the disease. In fact, in
several reported cases BRAO was only detected after repeated
FAG [6].
The diagnosis of Susac syndrome is straightforward, when the
characteristic clinical triad is complete, when the physician is
familiar with the clinical presentation, and when the crucial
diagnostic procedures are carried out and show characteristic
findings like BRAO in FAG. However, the diagnosis is often
complicated by the fact that the characteristic signs usually do not
occur concomitantly but rather develop successively with symp-
tom-free intervals [3], which often enough results in a delayed or
even completely missed diagnosis. Consensus criteria for the
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Susac syndrome usually presents with ‘‘punched-out’’ lesions,
frequently in the corpus callosum and periventricular area [11]. A
number of differential diagnoses, most of which occur more
frequently than Susac syndrome, have to be taken into consideration
[3]. In turn, Susac syndrome should be considered as differential
diagnosis in various conditions. Due to some overlap in the clinical
presentation and the patterns of MRI pathology multiple sclerosis
(MS) is probably the most frequent misdiagnosis of Susac syndrome
[2,8,11,12]. However, with respect to the different therapeutic
approach, particularly the necessity of a first-line immunosuppressive
treatment in Susac syndrome in contrast to primarily immunomod-
ulatory approaches in MS, a prompt establishment of the diagnosis is
essential. Additional diagnostic criteria allowing an early differential
diagnosis are therefore highly warranted.
Optical coherence tomography (OCT) has recently become a
valuable addition to the neurologist’s diagnostic toolbox, proving
its usefulness in a variety of disorders with neuro-ophthalmologic
involvement [13–16]. OCT facilitates e.g. non-invasive quantifi-
cation of both the thickness of the retinal nerve fibre layer
(RNFLT), which represents unmyelinated axons of retinal ganglia
converging to the optic disc to form the optic nerve and the
macular volume which represents the volume of the central retina
[13–16]. In a recently published case report we could demonstrate
pathologic OCT findings in a patient with Susac syndrome [3].
Based on these findings we hypothesised that retinal changes (i)
can be regularly detected by OCT in patients with Susac
syndrome and (ii) differ from retinal pathology observed in MS.
A different pattern of retinal pathology in Susac syndrome and MS
would be of clinical value in terms of distinguishing patients with
Susac syndrome from MS patients.
Methods
Objectives
To identify OCT changes in patients with Susac syndrome and
to compare these changes with matched healthy controls and
multiple sclerosis patients.
Table 1. Demographic overview of Susac patients included in
the study.
Subjects n 9
Eyes n 18
Gender Male (%) 3 (33)
Female (%) 6 (67)
Age (years) Mean 6 SD 33611
Min – Max 20–47
Time since diagnosis (months) Mean 6 SD 65655
Min – Max 3–173
Encephalopathy No (%) 1 (11)
Yes (%) 8 (89)
Hearing loss No (%) 0 (0)
Yes (%) 9 (100)
Visual impairment (eyes) No (%) 3 (17)
Yes (%) 15 (83)
No (%) 3 (17)
Yes (%) 15 (83)
Abbreviations: BRAO = branch retinal artery occlusion, SD = standard
deviation.
doi:10.1371/journal.pone.0038741.t001
Table 2. Optical coherence tomography data of the nine patients with Susac syndrome.
Pat. Sex Age Dur. Eye VS BRAO
TMV
[mm
3]A [ mm] T [mm] S [mm] N [mm] I [mm]
P1 m 20 26 OD yes yes 6.00 85 48 101 70 122
OS yes yes 7.22 83 65 107 47 115
P2 m 32 58 OD yes yes 7.64 105 81 132 106 102
OS no yes 7.66 108 77 141 98 115
P3 f 44 173 OD yes yes 5.67 61 51 54 51 88
OS yes yes 6.11 61 49 64 53 77
P4 m 39 50 OD yes no 5.70 60 53 78 49 59
OS yes yes 6.63 82 63 95 60 111
P5 f 22 41 OD yes yes 6.26 67 65 58 64 83
OS yes yes 6.21 73 67 69 67 89
P6 f 30 128 OD no no 6.61 88 76 84 71 121
OS no no 6.64 93 70 125 64 115
P7 f 20 66 OD yes yes 6.52 96 74 103 74 131
OS yes yes 6.86 115 72 132 107 149
P8 f 45 69 OD yes yes 5.25 62 52 70 41 83
OS yes yes 5.55 52 57 56 31 65
P9 f 47 3 OD yes yes 6.66 86 74 103 63 103
OS yes yes 6.57 79 69 99 56 93
Abbreviations: Pat. = Patient No; Age = age of onset; Dur. = time since diagnosis at time of OCT measurement in months; OD = right eye; OS = left eye; VS = visual
symptoms; BRAO = branch retinal artery occlusion; TMV = total macular volume in mm
3; A = average retinal nerve fibre layer thickness (RNFLT) in mm; T = temporal,
S = superior, N = nasal, I = inferior quadrant’s RNFLT in mm.
doi:10.1371/journal.pone.0038741.t002
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This is a prospective, cross-sectional, multicentre observational
study documenting OCT findings in Susac syndrome patients.
Patients with definite diagnosis of Susac syndrome, aged $
18 years were recruited from the neurologic outpatient clinics of
five large university medical centres (Berlin, Mu ¨nster, Du ¨sseldorf,
Hamburg, and Wu ¨rzburg, Germany). Exclusion criteria were
inability to provide informed consent. All included patients
underwent complete neurological examination. Medical history,
particularly with respect to encephalopathy, visual symptoms, and
hearing loss was taken from all study participants. In cases where
the classical clinical triad was not present, diagnosis was
established on clinical presentation and MRI findings. Visual
testing was performed with bedside visual field testing. Age and
gender matched healthy controls (HC) and patients with relapsing
remitting MS (RRMS) were randomly selected from the imaging
research database of the NeuroCure Clinical Research Center
(NCRC) at Charite ´ – Universita ¨tsmedizin Berlin by an investigator
blinded to the OCT data.
Ethics
The study was approved by the local ethics committees and was
conducted in accordance to the Declaration of Helsinki in its
currently applicable version, the guidelines of the International
Conference on Harmonisation of Good Clinical Practice (ICH-
GCP), and the applicable German laws. All participants gave
informed written consent.
Optical Coherence Tomography
RNFLT and TMV were measured with Stratus 3000 OCT
(Carl Zeiss Meditec, California, USA) using ‘‘Fast RNFL 3.4’’ and
‘‘Fast Macula Thickness Map’’ protocols (software V4.0) by
trained personnel. For RNFLT, a 3.4 mm diameter circular scan
was acquired circumferentially to the optic disc, and for TMV six
radial lines were taken, centred within the fovea. A good quality
image was defined as having generalised signal distribution, a
reflectance signal from either RNFL or retinal pigment epithelium
strong enough to identify either layer, no missing parts caused by
eye movements, and a signal strength of $7 of 10 [17].
Segmentation lines for upper and lower borders of RNFL were
required to be on the internal limiting membrane and lower
border of the RNFL. For the comparison of OCT measurements
to normative data, the device’s internal normative database,
comprising of measurements of 170 eyes from HC was used as a
reference. Percentile positions of measurements compared to these
normative data are automatically given on the device’s TMV and
RNFLT report as below 1
st percentile, between 1
st and 5
th
percentile, between 5
th and 95
th percentile, and above 95
th
percentile.
Statistical methods
Differences in age and time since diagnosis between patients
with Susac syndrome, HC and RRMS patients with and without a
history of optic neuritis were analysed using Friedman’s analysis
for matched pairs. Differences between eyes from the groups were
assessed using generalised estimating equation models (GEE)
accounting for intra-patient/inter-eye dependencies. To further
rule out possible age related effects or effects related to minor
differences in time since diagnosis, GEE models were corrected for
age and additionally with time since diagnosis for comparisons
against RRMS patients. In all GEE, the diagnostic group was used
as independent categorical variable. Mean values in text are given
with standard deviation (SD) after a 6 sign. All statistical tests
were performed using SPSS 20 (IBM, Somers, NY, USA). For all
calculations, statistical significance was established at p,0.05.
Results
Cohort description
Nine patients with Susac syndrome were prospectively recruited
(six jointly from Berlin and Mu ¨nster, one from each of the other
Table 3. Mean values from optical coherence tomography measurements of the macula (total macular volume and below) and
the circular scan around the optic nerve head (RNFLT Average and below).
Susac HC MS-NON MS-ON
Mean SD Min Max Mean SD Min Max Mean SD Min Max Mean SD Min Max
Total Macular Volume
[mm
3]
6,43 0,67 5,25 7,66 7,14 0,35 6,65 7,84 7,09 0,36 6,51 7,75 6,73 0,49 6,04 7,68
Inner Macula T [mm] 240 33 172 284 269 18 238 296 269 13 237 286 253 20 220 294
S[ mm] 242 55 128 300 283 16 255 308 281 17 239 301 265 19 237 296
N[ mm] 271 26 207 306 282 17 256 312 279 16 243 302 266 19 241 302
I[ mm] 254 42 146 301 280 18 254 311 281 12 258 301 260 21 232 304
Outer Macula T [mm] 205 27 160 243 229 11 213 252 229 11 211 251 219 18 193 252
S[ mm] 209 42 139 263 247 12 231 276 245 14 222 266 234 17 209 263
N[ mm] 246 18 211 267 264 14 248 291 262 16 232 291 248 18 214 281
I[ mm] 222 30 143 265 242 12 223 262 241 11 216 267 226 18 200 266
RNFLT Average [mm] 81 18 52 115 107 9 91 120 102 14 87 137 95 11 74 118
RNFLT T [mm] 65 11 48 81 75 12 59 101 73 17 49 109 57 14 29 77
S[ mm] 93 28 54 141 133 14 104 158 123 17 104 164 113 16 87 150
N[ mm] 65 21 31 107 85 16 67 120 82 21 47 142 90 16 62 123
I[ mm] 101 24 59 149 132 14 109 150 128 17 105 163 120 16 89 139
Abbreviations: RRMS = relapsing-remitting multiple sclerosis; HC = healthy controls; SD = standard deviation; RNFLT = retinal nerve fibre layer thickness; t =
temporal; S = superior; N = nasal; I = inferior.
doi:10.1371/journal.pone.0038741.t003
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multiple case presentation is provided in table 2. The female to
male ratio of 2:1 reflected that reported in the literature. All
patients had a history of hearing loss, and all but one patient (P2)
had symptoms of encephalopathy. All patients except one (P6) had
a history of visual symptoms and provided accompanying reports
of BRAO. Additionally, one patient (P2) had visual symptoms on
the right eye. However, in this patient a report of BRAO did exist
for both eyes. At the time of OCT investigation, no patient was in
a clinically active phase of the disease.
Macular and retinal nerve fibre layer damage
Single case OCT measurements are given in table 2, and a
synopsis is provided in table 3. In summary, compared to the
normative database of the OCT device, most patients showed a
reduction in either average RNFLT or macular measurements. All
but one patient (P2) with a history of visual symptoms showed
either reduced average RNFLT and/or diminished TMV in at
least one eye. P2 showed a very mild clinical phenotype and TMV
was above the 95
th percentile when compared to the normative
database of the device. Interestingly, one patient without visual
symptoms and without documented BRAO (P6) did also present a
pathological OCT with a strong RNFLT reduction in the superior
quadrant of the right eye, although average RNFLT in this eye
was normal (figures 1 and 2).
Importantly, TMV and RNFLT reduction were not evenly
distributed over the entire scanning area but scattered over all
sectors (figure 1 and figure 2). Patients with Susac syndrome
showed a RNFLT below the 5
th percentile in a mean 3.663.4
(range 0–10) of the twelve clock-hour sectors and a TMV below
the 5
th percentile in a mean 2.462.9 (range 0–7) of the nine
macular sectors whereas the other sectors were within normal
ranges. All but one patient (P2) showed this patchy retinal damage
in at least one eye as indicated by the yellow and red areas in the
RNFLT measurements and the dark blue areas in the TMV
measurements (figure 1).
Comparison to matched healthy controls and multiple
sclerosis patients
To compare OCT results from patients with Susac syndrome to
results from HC and RRMS patients, either group of nine gender
and age matched HC (mean age 33611 years, 3/6 male/female),
nine RRMS patients without any history of optic neuritis (mean
age 32610 years, 3/6 male/female, time since diagnosis 55640
months) and nine RRMS patient with a previous bilateral optic
neuritis (mean age 3369 years, 3/6 male female, time since
diagnosis 38640 months) was considered. HC and RRMS
patients were matched for gender, age and time since diagnosis.
Gender was matched exactly 1:1. The differences in age were not
significant (Friedman’s analysis for matched pairs p=0.661).
Likewise, time since diagnosis of RRMS patients with and without
previous optic neuritis was statistically not different from Susac
patients (Friedman’s analysis for matched pairs p=0.062).
Average RNFLT was reduced in patients with Susac syndrome
(average RNFLT 81618 mm, table 3) in comparison to HC
(average RNFLT 10769 mm, coefficient B=225.5, SE 6.2,
p,0.001, GEE), RRMS patients without previous optic neuritis
(average RNFLT 102614 mm, coefficient B=221.3, SE 6.2,
p=0.001, GEE) and RRMS patients with a history of optic
neuritis (average RNFLT 95611 mm, coefficient B=213.5, SE
5.8, p=0.019, GEE) (figure 1B, 2 and 3). Accordingly, TMV was
reduced in patients with Susac syndrome (TMV 6.4360.67 mm
3,
table 3) in comparison to HC (TMV 7.1460.35 mm
3, coefficient
B=20.71, SE 0.22, p=0.001, GEE), RRMS patients without
history of optic neuritis (TMV 7.0960.36 mm
3, coefficient
B=20.67, SE 0.20, p=0.001, GEE) but not against RRMS
patients with previous history of optic neuritis (TMV
6.7360.49 mm
3, coefficient B=20.23, SE 0.21, p=0.224,
GEE) (figure 1 and 3).
Discussion
In this cross-sectional, observational study we investigated nine
patients with Susac syndrome using OCT and compared RNFLT
and TMV data with nine gender and age matched HC and nine
RRMS patients each with or without history of optic neuritis. Our
main findings are (a) pathologic OCT measurements in most of
the Susac patients with a history of visual symptoms when
compared to the normative database of the OCT device; (b)
reduced RNFLT and macular measurements when compared to
gender and age matched HC; (c) a more severe retinal nerve fibre
damage in patients with Susac syndrome as compared to RRMS
patients irrespective the history of optic neuritis despite a similar
disease duration, and most importantly (d) distinct patterns of
retinal or retinal nerve fibre layer damage among patients with
Susac syndrome compared to RRMS patients that can help to
discriminate between both diseases.
Although a rare disease, Susac syndrome needs to be considered
in the differential diagnosis of a variety of neurological disorders.
Currently, its diagnosis is based primarily on the clinical
presentation, the documentation of BRAO by FAG, and
characteristic findings on cranial magnetic resonance imaging,
including subtle changes such as fibre impairment detected by
diffusion tensor imaging [18]. Recently, anti-endothelial antibod-
ies in Susac syndrome were reported as a potential future
diagnostic criterion and as a possible pathologic correlate [19,20].
The majority of patients with Susac syndrome in this study
showed a characteristic and thus very distinct pattern of often
severe and patchy retinal nerve fibre thinning in RNFLT and
retinal damage in TMV. Compatible with the pathology of this
retinal microangiopathy, retinal damage was usually scattered over
distinct foci and not evenly distributed: whereas several sectors in
RNFLT and/or TMV showed severe damage, other sectors
remained completely normal. The notable exclusion from that rule
was patient P2, who had a mostly normal RNFLT and TMV,
despite visual symptoms and BRAO findings in FAG.
Figure 1. Macular and ring scans from patients with Susac syndrome and matched RRMS patients. Shown are only the left eyes
(randomly selected to save space) from each Susac patient (P1-9) and the corresponding left eyes from RRMS patients without history of optic neuritis
(MS-NON) and RRMS patients with history of optic neuritis (MS-ON). On the bottom, a comparison of scans from one of the healthy controls is given.
A) Colour coded is the calculated macular thickness from the device’s segmentation algorithm with black to blue for reduced thickness and yellow to
green for normal thickness (left legend on the bottom). The macular thickness map is calculated from six linear scans through the centre of the
macula. Of note is the different distribution of the damage. B) For RNFLT scans, the thickness from 12 clock-hour segments of the circular scan is
given. Colour coded is the thickness relative to the normative database with green and white meaning normal values above the 5
th or 95
th percentile
and yellow and red meaning reduction of thickness below the 5
th or 1
st percentile (right legend on the bottom). Whereas some Susac patients’ eyes
show striking sectoral damage, eyes from RRMS patients show an even thinning with an accentuation in the outer temporal areas, that is further
pronounced with a history of optic neuritis. Three Susac patients (P6, 7, 9) show a similar pattern.
doi:10.1371/journal.pone.0038741.g001
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OCT findings in MS. Several publications that were recently
reviewed in a meta-analysis [16], report an evenly distributed
thinning of RNFL in MS that is slightly enhanced on the temporal
quadrant after optic neuritis [21]. However, RNFL thinning in
MS accumulates over time and becomes more severe especially in
later stages of the disease. In early stages of MS and in clinically
isolated syndrome (CIS), when differentiation of Susac syndrome is
most important, RNFL thinning is barely detectable [22].
However, since Susac patients in this study’s cohort had an
P3
P5
P1
P2
P4
P6
P7
P8
P9
Susac MS-NON MS-ON
Figure 2. RNFLT from patients with Susac syndrome and matched RRMS patients. Shown are only the left eyes (randomly selected to save
space) from each Susac patient (P1-9) and the corresponding left eyes from RRMS patients without history of optic neuritis (MS-NON) and RRMS
patients with history of optic neuritis (MS-ON). Each graph represents the RNFLT from a peripapillary ring scan. Colour coded is the thickness relative
to the normative database with green and white meaning normal values above the 5
th or 95
th percentile and yellow and red meaning reduction of
thickness below the 5
th or 1
st percentile. Abbreviations: RNFLT = retinal nerve fibre layer thickness.
doi:10.1371/journal.pone.0038741.g002
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not clear, how early Susac syndrome with acute visual impairment
and BRAO translate into pathological OCT findings.
The crucial question in this context is at what time point OCT
starts to show abnormal findings in patients with Susac syndrome.
A few case reports and one study with nine BRAO patients
without underlying Susac syndrome report an initial thickening of
RNFL leading to final thinning after several months [23–25]. In
general, one would suspect that structural retinal nerve fibre
damage evolves some time after the underlying vessel pathology.
One patient (P6) however showed an abnormal OCT even
without BRAO in FAG pointing towards a potential usability of
OCT in earlier stages of the disease when the diagnosis is yet not
fully established. This issue should be addressed in a longitudinal
study investigating the development of retinal lesions of newly
diagnosed patients with Susac syndrome and BRAO over time
including functional visual outcomes. Due to the design of our
study, it was not possible to perform FAG and OCT at the same
time, unfortunately limiting the possibility to make assertions on
the co-occurrence of OCT and BRAO findings in this respect.
Therefore, these questions are currently investigated in a follow up
study.
Beyond differential diagnosis, the severe structural retinal
damage in Susac syndrome especially in the macular scans
detected by OCT supports an aggressive treatment regimen early
after diagnosis [8]. This notion is further assisted by the fact that
patient (P6) without visual symptoms showed a pathological OCT,
suggesting early subclinical retinal damage. On the other hand,
one patient (P2) with actual BRAO did not have pathological
findings in OCT. Thus, BRAO does not always lead to
pathological OCT findings. The dissociation of retinal damage
and history of BRAO observed in P2 and P6 might suggest
additional mechanisms independent of BRAO underlying retinal
damage in this disease.
The reported study has important limitations that need to be
considered. Due to the rarity of the disease, recruitment of a
sufficient number of patients is challenging and prospective data
on Susac syndrome derived from studies with more than five
patients hardly exist. Although data on a limited number of nine
patients obviously need to be interpreted cautiously, our study is
among the largest prospective studies so far reported on Susac
syndrome [26–28]. However, conclusions on the discriminatory
ability of OCT between Susac syndrome and MS should be
interpreted with care from this study with only small numbers.
Another important limitation of our study is the use of a time
domain OCT device that measures macular volume using a six-
line scan protocol instead of a volume/3D scan. A thickness map is
generated via interpolating the measurements between the six line
scans. The distinct and striking sectorial damage in the macular
scans might therefore be under- or overestimated. Since the
macular scan incorporates all retinal layers between the inner
limiting membrane and the retinal pigment epithelium, it is not
possible to determine via time domain OCT alone, which retinal
layers are affected in Susac syndrome in comparison to optic
neuritis. Because of the vascular nature of the disease, one might
speculate though, that any damage would be more profound and
affecting more retinal layers when compared to optic neuritis.
Furthermore, the used time domain OCT device has known
limitations in the reproducibility of sectoral RNFLT [29]. Next
generation spectral domain OCT devices provide volume 3D
scans and intra-retinal segmentation algorithms [30], possibly
further enhancing the value of OCT in the differential diagnosis of
Susac syndrome. However, in contrast to spectral domain OCT,
time domain OCT is already widely available and patients with
Susac syndrome show the reported distinct phenotype in
comparison to MS even in time domain OCT, thus strengthening
the importance of OCT application in differential diagnosis in
routine or outpatient clinic settings.
In summary, we show that Susac patients regularly have distinct
abnormalities in OCT scans. The sectorial pattern of retinal
damage supports the hypothesis of a vascular origin with patchy
lesions. Most importantly, our data recommends OCT as a tool in
early primary and secondary diagnostics of Susac syndrome when
differentiation from MS and other neuroimmunologic diseases can
prove challenging.
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